AEYE Health Announces Yonatan Raz-Fridman as Chief Business Officer to Propel AEYE-DS U.S. Market Expansion

UMass Memorial Health integrates AEYE Health's AEYE-DS into its EMR system

Zack Dvey-Aharon, Co-Founder and CEO of AEYE Health, Named to TIME's 2024 Annual List of the TIME 100 AI

EYE Health, Optomed to launch tool for diabetic retinopathy screening

FDA Clears First Fully Autonomous AI for Portable Diabetic Retinopathy Screening

FDA clears first fully autonomous AI for portable diabetic retinopathy screening

FDA Clears AEYE Health's Autonomous AI for Portable Diabetic Retinopathy Screening

AEYE Health and Topcon Screen Announce Partnership to Enhance Point-of-Care Diabetic Retinopathy Screening with Best-in-Class AI Technology

The Bethesda Health Clinic implements AEYE Health's AI-based Screening Technology to Provide the Working But Uninsured East Texans with Free Diabetic Retinopathy Screenings

IRIS and AEYE Health Announce Partnership to Provide AI Screening to Market

AEYE Health receives FDA 510(k) for AI-backed diabetic retinopathy screening

Eye AI? Aye-aye, FDA tells AEYE

AEYE Health gains FDA clearance to screen diabetics to head off blindness

AEYE Health gets FDA approval to screen diabetics to prevent blindness

FDA Green Lights AEYE Health’s AI-Based Autonomous Screening for Referable Diabetic Retinopathy

AEYE Health reports results of its AI algorithm for autonomous screening and detection of diabetic retinopathy

AEYE Health Appoints Renowned Ophthalmologist Dr. Pamela F. Gallin as Chief Medical Officer to Support AEYE-DS' Rapid US Expansion

UMMH integrates AEYE Health’s diagnostic tool into EMR system for eye care

TIME 100/AI

AEYE Health and Optomed to Launch Aurora AEYE: The First Portable, AI-Powered Diabetic Retinopathy Screening Solution that Provides On-the-Spot Diagnosis

Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod

AI Is Moving Biology From Science To Engineering, Advancing Medicine

FDA Authorizes Autonomous AI for Portable Diabetic Retinopathy Screening

AEYE Health announced that it reduced the diagnostic processing time for AEYE-DS diabetic retinopathy screening system to under 5 seconds

IRIS and AEYE Health partner to bring AI technology integrations to more providers and simplify diabetic retinopathy screenings

What Drives Israel At 75? ‘Everything Is Possible’

​

AI Screening System For Blindness Associated With Diabetes Gets FDA Nod

AEYE Health Gets FDA Approval to Screen Diabetics to Prevent Blindness

AI For Diabetic Retinopathy Screening Gets U.S. FDA Approval

AEYE Health receives FDA clearance for AI-based autonomous screening for referable diabetic retinopathy

מונעת עיוורון: Aeye Health פיתחה תוכנת AI לאבחון סוכרת דרך הרשתית

UMass Medical School and AEYE Health Leverage Artificial Intelligence to Help Family Physicians Assess and Refer patients with Eye Conditions to Specialists

AEYE Health and Ford Medical Partner to Bring Fully Autonomous, Reimbursable AI Diabetic Eye Exam Screening Solutions to Pharmacies

UMass Memorial Health Integrates AEYE Health's AEYE-DS Autonomous AI Screening for Diabetic Eye Care into EMR System

AEYE Health, Optomed to launch tool for diabetic retinopathy screening

Revolutionizing diabetic retinopathy screening with AI

FDA approves the first fully autonomous AI for portable diabetic retinopathy screening

FDA clears fully autonomous AI for portable diabetic retinopathy screening

AEYE, Topcon Screen partner on AI-based diabetic retinopathy screening

AEYE Health Makes Its One-Image-Per-Eye Diabetic Eye Exam Even Faster by Cutting Processing Time to Under 5 Seconds

AEYE Health Welcomes Renowned Physician Guillermo Umpierrez, MD, CDCES as New Medical Board Advisor, and Prepares for Engaging Exhibitions at ENDO 2023 and ADA's 83rd Scientific Sessions

AI Takes Root in Primary Care. First Stop: Diabetic Retinopathy

AEYE Health wins FDA clearance for AI-powered eye test to expand diabetic screening

Aeye eyes ‘aye’ from FDA for AI tool to prevent diabetes-related blindness

AEYE Health gets FDA approval to screen diabetics to prevent blindness

AEYE Health gets FDA clearance to use AI to screen diabetics in hopes of preventing blindness

AEYE Health Reports Pivotal Clinical Trial Results of its AI Algorithm for the Autonomous Screening and Detection of More-Than-Mild Diabetic Retinopathy